Peripheral Vascular Device Market Report 2024-2034

Peripheral Vascular Device Market Report 2024-2034

The Peripheral Vascular Devices Market Report 2024-2034: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

R&D Investments Projected to Drive Industry Growth

Market participants are engaging in R&D investment to manufacture innovative peripheral vascular devices, aiming to enhance their effectiveness and safety while also raising public awareness through the introduction of new technologies and treatments. For instance, in March 2024, Medtronic expanded its Medtronic Engineering and Innovation Center (MEIC) in Hyderabad as part of its commitment to invest over $350 million over five years. This investment is intended to bolster the research and development capabilities of the center and increase its workforce from approximately 950 employees to 1,500. On 1st December 2023, BIOTRONIK unveiled the inauguration of its latest Asia Pacific Manufacturing and Research Hub. Spanning 20,000 m², the site is designated as the primary center for BIOTRONIK's operations including manufacturing, R&D, and sales & marketing in the Asia Pacific region. This new facility will contribute expertise across various therapy domains, including interventional cardiology, peripheral interventions, cardiac rhythm management, endoscopy, neuromodulation, and urology and pelvic health, thereby strengthening Boston Scientific's presence and capabilities in India.

Product Recall Likely to Challenge Industry Growth

The market growth of peripheral vascular devices has been significantly hampered by product recalls, eroding consumer trust, heightening regulatory scrutiny, imposing financial burdens on manufacturers, and intensifying market competition. In 2023, Cordis US Corp recalled the INFINITI Angiographic Catheter due to shipment without proper sterilization procedures, while Terumo Aortic recalled specific lots of the TREO Abdominal Stent-Graft Systems due to potential issues with graft sizes. Similarly, in April 2024, the FDA issued a Class I Recall for 330,000 Radial Artery Catheterization Kits manufactured by Teleflex and Arrow International. A total of 334,995 affected devices were distributed between December 2021 and January 2024.

These recalls undermine confidence in affected brands or product categories, leading to decreased demand and reluctance to use similar devices among patients and healthcare providers. Regulatory agencies may impose stricter approval requirements, slowing down the entry of new products into the market. Manufacturers incur significant costs related to recalls, investigations, and compensating affected individuals, impacting profitability and research and development investments. Competitors may seize the opportunity to gain market share by offering perceived safer alternatives, heightening competition within the peripheral vascular devices market.

What Questions Should You Ask before Buying a Market Research Report?

• How is the peripheral vascular devices market evolving?
• What is driving and restraining the peripheral vascular devices market?
• How will each peripheral vascular devices submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2034?
• How will the market shares for each peripheral vascular devices submarket develop from 2024 to 2034?
• What will be the main driver for the overall market from 2024 to 2034?
• Will leading peripheral vascular devices markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2034 and which geographical region will lead the market in 2034?
• Who are the leading players and what are their prospects over the forecast period?
• What are the peripheral vascular devices projects for these leading companies?
• How will the industry evolve during the period between 2024 and 2034? What are the implications of peripheral vascular devices projects taking place now and over the next 10 years?
• Is there a greater need for product commercialisation to further scale the peripheral vascular devices market?
• Where is the peripheral vascular devices market heading and how can you ensure you are at the forefront of the market?
• What are the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the peripheral vascular devices market today, and over the next 10 years:

• Our 325-page report provides 150 tables and 240 charts/graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them – NOW.
• It contains in-depth analysis of global, regional and national sales and growth.
• It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the peripheral vascular devices market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2034 and other analyses reveal commercial prospects

• In addition to revenue forecasting to 2034, our new study provides you with recent results, growth rates, and market shares.
• You will find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising peripheral vascular devices prices and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.

Segments Covered in the Report

Product

• Stents: Bare Metal Stents, Drug-eluting Stents
• PTA Balloons
• Catheters: Angiography Catheters, IVUS/OCT Catheters, Guiding Catheters
• Endovascular Aneurysm Repair Stent Grafts: Thoracic Endovascular Aneurysm Stent Grafts, Abdominal Endovascular Aneurysm Stent Grafts
• Plaque Modification Devices: Atherectomy Devices, Thrombectomy Devices
• Inferior Vena Cava Filters: Permanent Filters, Retrievable Filters
• Hemodynamic Flow Alteration Devices: Chronic Total Occlusion Devices, Embolic Protection Devices
• Others: Guidewires, Vascular Closure Devices, Balloon Inflation Devices, Introducer Sheaths

End-users

• Hospitals
• Ambulatory Surgical Centers (ASCs)
• Others

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 22 leading national markets:

North America

• U.S.
• Canada

Europe

• Germany
• UK
• France
• Spain
• Italy
• Russia
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia Pacific

Latin America

• Brazil
• Mexico
• Argentina
• Rest of Latin America

MEA

• GCC
• South Africa
• Rest of MEA

The report also includes profiles and for some of the leading companies in the Peripheral Vascular Devices Market, 2024 to 2034, with a focus on this segment of these companies’ operations.

Leading companies and the potential for market growth

• Abbott Laboratories
• B. Braun SE
• Becton, Dickinson and Company
• Biotronik SE & Co KG
• Boston Scientific Corporation
• Cardinal Health, Inc.
• Cook Group, Inc.
• Cordis Corp.
• Getinge AB
• Koninklijke Philips N.V.
• Kyoto Medical Planning Co., Ltd.
• Medtronic plc
• Merit Medical Systems, Inc.
• Penumbra Inc.
• Terumo Corporation

Overall world revenue for Peripheral Vascular Devices Market, 2024 to 2034 in terms of value the market will surpass US$12.0 billion in 2024, our work calculates. We predict strong revenue growth through to 2034. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Peripheral Vascular Devices Market, 2024 to 2034 report help you?

In summary, our 320+ page report provides you with the following knowledge:

• Revenue forecasts to 2034 for Peripheral Vascular Devices Market, 2024 to 2034, with forecasts for product and end-users, each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.
• Revenue forecasts to 2034 for five regional and 22 key national markets – See forecasts for the Peripheral Vascular Devices Market, 2024 to 2034 market in North America, Europe, Asia Pacific, Latin America, and MEA. Also includes forecast for the market in the U.S., Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market – including company profiles for 15 of the major companies involved in the Peripheral Vascular Devices Market, 2024 to 2034.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else

With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Peripheral Vascular Devices Market, 2024 to 2034, market-leading companies. You will find data, trends and predictions.

Please Note: Prior to initiating fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher..

The publisher is using a password system to access single user and team licenses. Single user (non-printable) and team licenses expire after 12 month period. In the case of team license purchases, the publisher requires all email addresses for the licensed users prior to fulfilment.